[Retracted] Influence of Melatonin Treatment on Emotion, Sleep, and Life Quality in Perimenopausal Women: A Clinical Study
Journal of Healthcare Engineering · 2023
DOI: 10.1155/2023/2198804 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Healthcare Engineering, 2023. Verfasst von Jianfu Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Ningbo Women and Children's Hospital, Ningbo 315012, China. Hauptthemen laut MEDLINE: Perimenopause, Melatonin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objects. Sleep and mood disorders are frequently observed in perimenopausal women, which may be associated with the changes of melatonin concentrations. Therefore, this study aimed at probing into the impact of melatonin on the improvement of sleep, mood symptoms, and quality of life (QoL) in perimenopausal women.
Method
100 healthy perimenopausal women were recruited and randomly assigned to two groups, with 50 subjects in each group. In the control group, placebo was administrated daily for 3 cycles (4 weeks of treatment for 1 cycle and drug withdrawals for 1 week). The study group received 3 mg oral melatonin treatment daily in the same period of time. All subjects completed the study. We compared the uterine volume, endometrial thickness, LH (luteinizing hormone), FSH (follicle generating hormone), E2 (estradiol), and melatonin levels during daytime between the two groups before and after the study. Moreover, perimenopause syndrome, sleep, mood, and QoL were analyzed at the baseline and 3 cycles by the questionnaires of the Kupperman index, the Pittsburgh sleep quality index (PSQI), the Hamilton anxiety scale (HAMA), and the Hamilton depression scale (HAMD), as well as menopausal QoL (MENQOL), respectively. Any adverse reactions experienced by the subjects were also compared in the study. Finally, 91 participants (92%) completed the whole study, 47 and 44 in the study and control groups, respectively, and their data were considered in subsequent analyses.
Results
After therapy, the two groups were similar in the uterine volume and endometrial thickness. In contrast to the control group, the study group showed notably decreased LH and FSH levels. No notable difference was discovered in E2 and melatonin levels between the two groups in the study. Moreover, the study group exhibited a significantly lower score in the Kupperman index, PSQI, HAMA, HAMD, and MENQOL scale than the control group. Moreover, the two groups had no notable difference in adverse reactions.
Conclusion
Melatonin was a useful treatment to relieve climacteric symptoms and improve sleep, mood, and life quality in perimenopausal women without obvious adverse reactions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Ningbo Women and Children's Hospital, Ningbo 315012, China.
- Department of Gynecology, Ningbo Women and Children's Hospital, Ningbo 315012, China.
ORCID-Profile: Bengui Jiang
Zitieren
APA
Zhang, J., & Jiang, B. (2023). [Retracted] Influence of Melatonin Treatment on Emotion, Sleep, and Life Quality in Perimenopausal Women: A Clinical Study. Journal of Healthcare Engineering. https://doi.org/10.1155/2023/2198804
Vancouver
Zhang J, Jiang B. [Retracted] Influence of Melatonin Treatment on Emotion, Sleep, and Life Quality in Perimenopausal Women: A Clinical Study. Journal of Healthcare Engineering. 2023. doi:10.1155/2023/2198804
BibTeX
@article{Zhang2023,
author = {Zhang, Jianfu and Jiang, Bengui},
title = {[Retracted] Influence of Melatonin Treatment on Emotion, Sleep, and Life Quality in Perimenopausal Women: A Clinical Study},
journal = {Journal of Healthcare Engineering},
year = {2023},
doi = {10.1155/2023/2198804}
}
EUVIMED